| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―May―01 |
Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern |
Nicole L. Inniss, Margarita Rzhetskaya, Ryan P. Kich, Elizabeth Gleason, Taha Y. Taha, Francisco J. Zapatero-Belinchón, Julia Rosecrans, Valentina Pedrero-Classen, Kenneth Huang, Gilles Degotte, Luca Lizzadro, Jason Pattie, Adam R. Renslo, George Minasov, Melanie Ott, Kelly E.R. Bachta, Karla J.F. Satchell, Judd F. Hultquist |
| 2 |
[GO] |
2025―Nov―21 |
High-Throughput Screening Identifies Non-nucleoside Inhibitors of the SARS-CoV-2 Polymerase with Novel Mechanisms |
Colin R. Woodford, Kristine E. Frank, Haizhong Zhu, Gilman Dionne, Michael R. Schrimpf, Sujatha M. Gopalakrishnan, Nathaniel L. Elsen |
| 3 |
[GO] |
2025―Aug―12 |
High Throughput Screening for SARS-CoV-2 Inhibitors Targeting 5 Helix Bundle |
Emery Smith, Qibin Geng, Justin Shumate, Yuka Otsuka, Louis Scampavia, Thomas D. Bannister, Timothy P. Spicer |
| 4 |
[GO] |
2025―Apr―09 |
SLAS special issue editorial 2025: Outcomes From Antiviral Drug Discovery for Pathogens of Pandemic Concern |
Timothy P. Spicer, Louis D. Scampavia |
| 5 |
[GO] |
2025―Feb―01 |
Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein |
Rui Tong Quek, Cyna R. Shirazinejad, Christina L. Young, Kierra S. Hardy, Samuel Lim, Phillip J. Elms, David T. McSwiggen, Timothy J. Mitchison, Pamela A. Silver |
| 6 |
[GO] |
2024―Nov―04 |
Rapid-response RNA-fluorescence in situ hybridization (FISH) assay platform for coronavirus antiviral high-throughput screening |
Ryan Chan, Christian Shema Mugisha, Vorada Chuenchob, Stephanie A. Moquin, Ujjini H. Manjunatha, Nadine Jarrousse, Vineet D. Menachery, Xuping Xie, Erika L. Flannery, Richard T. Eastman |
| 7 |
[GO] |
2024―Aug―23 |
High throughput screening for SARS-CoV-2 helicase inhibitors |
Yuka Otsuka, Eunjung Kim, Austin Krueger, Justin Shumate, Chao Wang, Bilel Bdiri, Sultan Ullah, HaJeung Park, Louis Scampavia, Thomas D. Bannister, Donghoon Chung, Timothy P. Spicer |
| 8 |
[GO] |
2024―Aug―23 |
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening |
Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, Yuka Otsuka, Justin Shumate, Ashley Cuell, Megan Tansiongco, Christina B. Cooley, Yanjun Chen, Agnieszka Dabrowska, Rahul Basu, Paulina Duhita Anindita, Dahai Luo, Peter I. Dosa, Daniel A. Harki, Thomas Bannister, Louis Scampavia, Timothy P. Spicer, Reuben S. Harris |
| 9 |
[GO] |
2024―Aug―17 |
Simultaneous Screening for Selective SARS-CoV-2, Lassa, and Machupo Virus Entry Inhibitors |
Yuka Otsuka, Lizhou Zhang, Huihui Mou, Justin Shumate, Claire E. Kitzmiller, Louis Scampavia, Thomas D. Bannister, Michael Farzan, Hyeryun Choe, Timothy P. Spicer |
| 10 |
[GO] |
2024―Aug―14 |
Development of a Sensitive High-throughput Enzymatic Assay Capable of Measuring Sub-nanomolar Inhibitors of SARS-CoV2 Mpro |
Peter Kovar, Paul L Richardson, Alla Korepanova, Gustavo A Afanador, Vladimir Stojkovic, Tao Li, Michael R Schrimpf, Teresa I Ng, David A Degoey, Sujatha M Gopalakrishnan, Jun Chen |
| 11 |
[GO] |
2024―May―16 |
A High-throughput Response to the SARS-CoV-2 Pandemic |
Lynn Rasmussen, Shalisa Sanders, Melinda Sosa, Sara McKellip, N. Miranda Nebane, Yohanka Martinez-Gzegozewska, Andrew Reece, Pedro Ruiz, Anna Manuvakhova, Ling Zhai, Brooke Warren, Aliyah Curry, Qinghua Zeng, J. Robert Bostwick, Paige N. Vinson |
| 12 |
[GO] |
2024―Feb―01 |
Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays |
Nicole L. Inniss, Margarita Rzhetskaya, Ted Ling-Hu, Ramon Lorenzo-Redondo, Kelly E. Bachta, Karla J.F. Satchell, Judd F. Hultquist |
| 13 |
[GO] |
2023―Jul―18 |
Role Of Vaccines Against COVID-19 Pandemic |
Professor Dr. Batool Mutar Mahdi, Dr. Mustafa Almukhtar |
| 14 |
[GO] |
2023―Jan―14 |
High Throughput Screening for Drugs that Inhibit 3C-Like Protease in SARS-CoV-2 |
Emery Smith, Meredith E. Davis-Gardner, Ruben D. Garcia-Ordonez, Tu-Trinh Nguyen, Mitchell Hull, Emily Chen, Xuerong Yu, Thomas D. Bannister, Pierre Baillargeon, Louis Scampavia, Patrick Griffin, Michael Farzan, Timothy P. Spicer |
| 15 |
[GO] |
2022―Jun―04 |
Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens |
Serena Nihal, Kristyan Guppy-Coles, Mahnaz D. Gholami, Chamindie Punyadeera, Emad L. Izake |
| 16 |
[GO] |
2022―Jan―25 |
Identification of potent small molecule inhibitors of SARS-CoV-2 entry |
Sonia Mediouni, Huihui Mou, Yuka Otsuka, Joseph Anthony Jablonski, Robert Scott Adcock, Lalit Batra, Dong-Hoon Chung, Christopher Rood, Ian Mitchelle S. de Vera, Ronald Rahaim Jr., Sultan Ullah, Xuerong Yu, Yulia A. Getmanenko, Nicole M. Kennedy, Chao Wang, Tu-Trinh Nguyen, Mitchell Hull, Emily Chen, Thomas D. Bannister, Pierre Baillargeon, Louis Scampavia, Michael Farzan, Susana T. Valente, Timothy P. Spicer |
| 17 |
[GO] |
2022―Jan―25 |
Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection |
Rui Ge, Zuyuan Shen, Jian Yin, Wenhua Chen, Qi Zhang, Yulong An, Dewei Tang, Alexander L. Satz, Wenji Su, Letian Kuai |
| 18 |
[GO] |
2022―Jan―25 |
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry |
Miao Xu, Manisha Pradhan, Kirill Gorshkov, Jennifer D. Petersen, Min Shen, Hui Guo, Wei Zhu, Carleen Klumpp-Thomas, Sam Michael, Misha Itkin, Zina Itkin, Marco R. Straus, Joshua Zimmerberg, Wei Zheng, Gary R. Whittaker, Catherine Z. Chen |
|
